Christopher M. Crane - 08 Feb 2022 Form 4 Insider Report for EXELON CORP (EXC)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
10 Feb 2022, 19:02:06 UTC
Prior SEC filing
10 Jan 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Elizabeth M. Hensen, Attorney-in-Fact for Christopher M. Crane

Key filing fact

Christopher M. Crane filed Form 4 for EXELON CORP (EXC) on 10 Feb 2022.

Key facts

  • This page summarizes Christopher M. Crane's Form 4 filing for EXELON CORP (EXC).
  • 5 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 10 Feb 2022, 19:02.

Change

  • Previous filing in this sequence was filed on 10 Jan 2022.
  • Current net transaction value: -$6,302,172.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EXC transaction

Common Stock

Options Exercise

Transaction value
Shares
+109,928
Change %
+37%
Price
Shares after
404,180
Date
08 Feb 2022
Ownership
Direct
Footnotes
F1
EXC transaction

Common Stock

Tax liability

Transaction value
$2,793,290
Shares
-48,723
Change %
-12%
Price
$57.33
Shares after
355,457
Date
08 Feb 2022
Ownership
Direct
EXC transaction

Common Stock

Disposed to Issuer

Transaction value
$3,508,883
Shares
-61,205
Change %
-17%
Price
$57.33
Shares after
294,252
Date
08 Feb 2022
Ownership
Direct
EXC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
28,500
Date
08 Feb 2022
Ownership
Held by trust for benefit of son
EXC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
28,500
Date
08 Feb 2022
Ownership
Held by trust for benefit of daughter

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EXC transaction Derivative

Performance Shares 2019-2021

Award

Transaction value
Shares
+109,928
Change %
Price
Shares after
109,928
Date
08 Feb 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
109,928
Exercise price
$0.000000
Footnotes
F2, F3
EXC transaction Derivative

Performance Shares 2019-2021

Options Exercise

Transaction value
Shares
-109,928
Change %
-100%
Price
Shares after
0
Date
08 Feb 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
109,928
Exercise price
$0.000000
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Common shares acquired through conversion of previously granted and vested performance share award under the Exelon Long Term Incentive Plan.

Footnote F2

Performance share award granted pursuant to the Exelon Long Term Incentive Plan for the three-year performance period referenced in Column 1 based on the Compensation Committee's determination of performance achieved for the period. Each performance share represents the right to receive one share and/or cash pursuant to the Plan's terms with respect to individual stock ownership levels. Performance share awards vest immediately upon their grant date.

Footnote F3

Performance criteria was approved by the Exelon Compensation Committee; however Mr. Crane's award amount was further subject to Exelon board approval.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .